chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immunization (Influenza) at 3 pm. 9:30 pm - headache, chills, blurry vision, unsteady gait, back "soreness" symptoms continue today 11/14/12 with hives on inner thighs & side of knees.
Approx 5 minutes after receiving injection, pt began to complain of chest and neck tightness. Also complained of slight headache and "medicine taste" in her mouth. Skin warm and dry. Face flushed. Slight nausea. B/P 160/102, pulse 80. Declined to be transported to ER at local hospital. Her sister was notified and she took her to her primary care physician. Physician was notified of pt's condition and record faxed.
On 7/21/14 7 hours post vaccination child taken to hospital for diaphoresis, lethargy and difficulty breathing.
"Flu-like" sx that resolved; then a few days later (under a week) followed by painful hypersensitivity that was disabling to the point of changing activities.  Wearing clothing was painful as was urination.  Took anti-inflammatory agent with some sx relief.
I inserted the syringe/needle combo into the patients arm and when I tried to depress the plunger it would not move and I couldn't administer the solution in the syringe. I had to remove the needle from her arm and remove the defective needle and replace it with a new one. I had to insert the needle a second time to administer the vaccine.
About 4-5 hours after vaccine given broke out in hives-upper inner thighs, through the night hives progressively, worsened. Went to ER 7 PM. Given Benadryl IM and predinsone PO. Prescription for Medrol pack. Discharged to home. Initially hives improved. Around noon hives increased. Called PMD , told to take more Medrol. By next AM hives gone. Started to reappear. Called PMD, went to see him and given prescription antihistamine. After several hours improved. By next day completely gone and have not recurred.
PATIENT RETURNED TO PHARMACY 10/13/17 TO REPORT THAT BEGINNING 10/10/2017 HER ARM BEGAN TO SWELL NEAR ELBOW. AREA WAS RED AND WARM TO TOUCH. HER DR INITIALLY DIAGNOSED HER WITH CELLULITIS AND TREATED HER WITH LEVAQUIN. AT A SUBSEQUENT APPOINTMENT HER DETERMINED IT WAS A SEVERE ADVERSE REACTION TO THE HIGH DOSE VACCINE AND ADVISED HER TO NOT GET HIGH DOSE FLU VACCINE IN THE FUTURE.
the shot was given 11.22.21.  he had cardiac arrest on 12.9.21.  there is no history of heart attacks in the family.  he had absolutely no warning that anything was wrong until he was having the heart attack.  out of the blue he started sweating profusely, feeling disoriented, and dizzy.  no chest pain or tightening.  he died in the emergency room, but using the paddles several times, they were able to bring him back to life.  it was established that the plaque in the wall of the left anterior descending artery burst and platelets went to the site causing a block/clot/full obstruction of the artery.    he walked 3-5 miles a day or biked 10 miles.  160 pounds and 6 feet tall.  no smoking and drank a beer a day, if anything.
Exhaustion, fever, nausea, joint swelling, constipation, body aches, uncontrollable crying, sleep pattern disruptions.
Projectile vomiting (no history of reflux), fever, jerking of hands and legs.
5 minutes after administration - vomiting.  15 minutes after administration - face, trunk and extremities developed erythematous bullae and hives.  20 minutes after administration - coughing, sneezing and vomiting.  Adverse reaction to varicella immunization.
Within minutes after shots, baby developed generalized pallor. Remained alert, smiling. Normal muscle tone and movements. Pallor lasted ~ 15-20 mins. Baby started to cry, flushed and sweaty then pale "blueness around nose." Alert. MD advised amb-ER. Baby admitted to hospital. 2nd episode-duration 30 min.  Nurse follow up on 07/22/04 states: "No new information."
Initial report received from consumer on 12 Sep 2014. A 70-year-old female patient, whose concomitant medications were not reported, had received a dose of FLUZONE HD (lot number, dose, dose number, route of vaccination not reported) in the left deltoid on 09 Sep 2014. The patient had previously received erythromycin. The patient had a medical history of percutaneous nephrostomy, arthritis, breast cancer. It was reported that, on an unspecified date, Tuesday at 19:00 hours, the patient developed chills and low grade fever and resolved. It was reported patient again chills, low grade fever, joint pain and had difficulty closing right hand and had aches. The patient required ER visit. Lab investigation details and corrective treatments were not reported. The outcome of the event was reported as unknown. Documents held by sender: None.
A round red patch at the injection site; Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of VACCINATION SITE ERYTHEMA (A round red patch at the injection site) and MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy ) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088B21A) for COVID-19 vaccination.     Concurrent medical conditions included Gestational diabetes. Concomitant products included INSULIN for Gestational diabetes, IRON for Iron supplementation, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 30-Oct-2020 and the estimated date of delivery was 30-Aug-2021. On 06-Aug-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy ). On 12-Aug-2021, the patient experienced VACCINATION SITE ERYTHEMA (A round red patch at the injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fortieth week of the pregnancy.  On 06-Aug-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy ) had resolved. On 13-Aug-2021, VACCINATION SITE ERYTHEMA (A round red patch at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication also includes nighty insulin, Novolin for gestational diabetes.  Treatment information was not provided.
Burning in the left side of my neck; Burning in the left side of my neck; My arm was also tingling and numb.; My arm was also tingling and numb.; Heart was pounding out of my chest; Extreme shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 46-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number: FF2588), via an unspecified route of administration, administered in left arm on 31Aug2021 10:30 (age at vaccination 46 years) as single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccine within four weeks. No List of any other medications the patient received within 2 weeks of vaccination. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. It was reported that on 09Sep2021 05:00, the patient woke up with a burning in the left side of her neck; her arm was also tingling and numb, left arm. Her heart was pounding out of her chest. Got up to walk around. That day had extreme shortness of breath. It was ended up going to the ER the next day for shortness of breath. Ended up in the ER again less than a week later and have been seeing a doctor. Shortness of breath was not getting better. The patient underwent lab tests and procedures which included Bio Nova test: negative on 13Sep2021. Patient was not tested positive for COVID-19 since the vaccination. The patient was not received any treatment for the events. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Pt experienced fever with coughing and congestion. Pt was tender over the maxillary sinuses.  Pt experienced shingles on the injection arm and hand from the thumb to the ring finger. He had a lump under the right axillary region approximately nickel size palpated by the mother. There were some lesions on the dorsal and ventral surfaces of the hand. There were a few vesicular lesions on the arms extended from the elbow to the hand. Pt also experienced pain. Pt recovered one week after onset. Pt was treated with Cefzil.
Initial report received from a healthcare professional on 13 August 2013. A 38-year-old female patient had received an intramuscular dose 1 of ADACEL  vaccine (batch number: U4313AA and site of administration was not reported) on 12 August 2013. The patent's health during pregnancy and risk factors were reported as "N/A". Concomitant medications and past medical history were not reported. Treatment for infertility was reported as "N/A". The patient was pregnant at the time of vaccination. The patient's last menstrual period date was 08 January 2013. The estimated dose of delivery was 08 October 2013. At the time of the report, the patient had not experienced any adverse events. Documents held by sender: none.
9:20 am received vaccination, monitored for 15 minutes, until 9:35 am. Client returned at 9:56 am stating " left side of throat sore/feels like swelling."  Client denied any issues swallowing or any other symptoms.  9:58 am took client to private area (bathroom), explained possible allergic reaction, need for epi pen and call 911 for assessment.  I (nurse) administered epi-pen 0.3 mg (lot # G201104X expiration 2/2022) administration left thigh muscle; b/p taken 140/82 client stated "high for her."  10:00 am client stated "feel better, swelling gone away since epi pen administration.  I (nurse) spoke with Program Director who called 911 @ 10:05 am; client continued to state swelling gone away, and feeling better "don't need to go to hospital. I (nurse educated client importance being assessed further, and that she will be given option for transport to ER. 10:10 am EMS arrived; client was walked outside by nurse and Program Manager to sit on bench.  I (nurse) gave report to EMS, who then directed client to get on stretcher for assessment and possible transport to ER. EMS stated unsure which hospital transport to until call re: all hospitals on divert.  Client was put into EMS vehicle.  10:24 am client returned to me (nurse) informing they did not take her to hospital, took blood pressure 166/93 "higher nervous."  Educated client importance following up with PMD before getting second Pfizer vaccination.
This spontaneous report as received from a Healthcare Worker refers to a female patient of unknown age. The patient was received her first dose of GARDASIL (lot # was not reported) on 12-AUG-2012 and the second dose of GARDASIL (lot # was not reported) on 14-DEC-2012. Healthcare worker stated the patient was in the office to receive her third dose of GARDASIL (lot # was not reported) on 27-FEB-2013. No adverse symptoms reported. This is one of two reports from the same source. Additional information has been requested.
Pt was admitted on 4/21 with bilateral lower extremity pain with inability to ambulate with leukocytosis. Pt was tested for COVID on 4/24 for SNF placement and was positive, but asymptomatic.
A partial dose (0.25mL) of the Moderna monovalent vaccine was administered to the patient instead of the recommended 0.25mL of the Moderna bivalent booster at 3:30PM. Patient and guardian left shortly after. Patient had no adverse symptoms. Provider reached out to father of patient and notified him of the error at 5:30PM.
Patient tested positive for COVID-19 on 8/6/21, hospitalized due to COVID-19 illness from 8/9/21 through 8/23/21.
Hemolytic anemia; vaccine dose number=4; vaccine dose number=4; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Feb2022 12:00 (Lot number: FL3198) at the age of 70 years as dose 4 (booster), single for covid-19 immunisation. Relevant medical history included: "Kidney transplant patient" (unspecified if ongoing). No known allergies. Concomitant medication(s) received within 2 weeks included: METOPROLOL; MYCOPHENOLATE; TACROLIMUS. Vaccination history included: Bnt162b2 (vaccine brand=Pfizer / BioNTech,, vaccine administration date=03Mar2022, vaccine lot number=EN6205,, vaccine dose number=1,, vaccine location=Left arm.), administration date: 03Mar2021, when the patient was 69 years old, for COVID-19 immunisation; Bnt162b2 (vaccine brand=Pfizer / BioNTech,, vaccine administration date=25Mar2021, vaccine lot number=ER2613,, vaccine dose number=2,, vaccine location=Left arm.), administration date: 25Mar2021, when the patient was 69 years old, for covid- 19 immunisation; Bnt162b2 (vaccine brand=Pfizer / BioNTech,, vaccine administration date=14Aug2021,, vaccine administration time=12:00AM, vaccine lot number=FA7484,, vaccine dose number=3,, vaccine location=Left arm.), administration date: 14Aug2021, when the patient was 69 years old, for COVID-19 immunisation. The following information was reported: OFF LABEL USE (medically significant), IMMUNISATION (medically significant) all with onset 03Feb2022 12:00 and all described as "vaccine dose number=4"; HAEMOLYTIC ANAEMIA (medically significant) with onset 06Feb2022 05:00, described as "Hemolytic anemia". Therapeutic measures were not taken as a result of haemolytic anaemia.  No follow-up attempts are possible. No further information is expected.
I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 7/6/2022 UTI (URINARY TRACT INFECTION)
severe cramps in legs and ankles, spots and red rashes over half of his body got to the where he couldn't walk, dizzy like he had vertigo, legs and ankles are swollen
Tingling in ring and pinky fingers of left hand after injection.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and hypertension. Concomitant medications included metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) escitalopram oxalate (LEXAPRO) and eicosapentaenoic acid ethyl ester (VASCEPA); all for unknown indications from unspecified dates. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 15:00, the patient experienced tingling in ring and pinky fingers of left hand after injection which persisted at least 1-day post-injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of events tingling in ring finger and pinky fingers was not resolved at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Had 3rd Moderna Shot and 3 weeks later was so weak he had to be hospitalized and has developed warm hemolytic anemia.
I hadn't gotten my period a week before 1st dose, and after the 1st dose I got my period 7 weeks later- so about 3 weeks late. Then after that for maybe 4 periods they were heavier and more painful. The last one I had was right before my booster and it was pretty normal and then I got my booster and they were painful again. The one after my booster was also late by 3-4 weeks and just irregular in general. My appointment with Doctor will be scheduled this week. This is still ongoing.
She developed fever, chills. The next morning she had left supraclavicular swelling and pain and tenderness and fatigue. She also had extreme pain to the injection site in left deltoid. She was treated with ice, Tylenol.
Information has been received from a pharmacist concerning a 58 year old female with no pertinent medical history or drug allergies who on 19-OCT-2007 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (lot# 658603/1081U0. Concomitant drug therapy included IMITREX, montelukast sodium, verapamil and ZYRTEC. On 20-OCT-2007 the patient developed shingles. The patient contacted the pharmacist for medical attention. No labs or diagnostic studies were performed. The patient was not recovered. There was no product quality complaint. Additional information has been requested.
I was with 4 grandchildren who were all sick. One of them had walking pneumonia. Within two days I had started developing a sore throat. I also had started to experience some coughing and sinus issues. I went to the urgent care where they did tests on me. I was negative for covid. I had to use a steroid inhaler because my coughing had became more intense. I also had chronic sinus congestion. It took me a month to get over my symptoms. I never lost my taste or smell. When I went to my primary care doctor in the middle of January 2022 she had did some blood work and saw that I had antibodies for covid. I was prescribed antibiotics at first but told to stop taking them once we saw that I had covid. I had a reoccurrence of the symptoms but it was much less intense. One day I woke up in late February 2022 when I had the sinus problem again. Then it went away. I had no coughing that time. I have been fine ever since then.
Achy; Fever; Some nausea; Had a bad reaction to that dose; Sick for 3-4 days; Not feeling good for 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a bad reaction to that dose), ILLNESS (Sick for 3-4 days), MALAISE (Not feeling good for 3-4 days), PAIN (Achy) and PYREXIA (Fever) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ), METFORMIN, OMEPRAZOLE, ROSUVASTATIN, TADALAFIL (CIALIS) and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On 20-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced VACCINATION COMPLICATION (Had a bad reaction to that dose), ILLNESS (Sick for 3-4 days) and MALAISE (Not feeling good for 3-4 days). On 21-Aug-2021, the patient experienced PAIN (Achy), PYREXIA (Fever) and NAUSEA (Some nausea). On 25-Aug-2021, PAIN (Achy), PYREXIA (Fever) and NAUSEA (Some nausea) had resolved. At the time of the report, VACCINATION COMPLICATION (Had a bad reaction to that dose) outcome was unknown and ILLNESS (Sick for 3-4 days) and MALAISE (Not feeling good for 3-4 days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, Body temperature: 100 (High) Temperature never went above 100 degrees Fahrenheit.         Patient stated that he may have taken Ibuprofen but does not remember. Patient weight was reported as 215.
achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN (achy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (achy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicines include cholesterol medicine, blood pressure medicine. Treatment medicine include Tylenol.
3-5 minutes after the dose, thundering chest beat of my heart - 135 heartbeat and laid down for a while and it went down for 30 minutes and my oxygen was maintained by medical health personal, went to ER. Blood pressure and heartrate kept going high. Was there for 8 hrs. 135 heartrate ER borderline EKG. ordered ECHO. I still have pounding of the health but much better now. 1st and 2nd shot COVID-19 vaccine with regards to my elevated with my heart rate.
About 20min after receiving her first Covid-19 vaccine on 4/8/21, patient experienced right facial numbness. Over the next two days patient experienced partial left sided facial numbness that was persistant. The third day, it was right sided again and stayed on the right side of the face and right side of the body. It started to become intermintant. She would wake without symptoms, and then symptoms would start mid day, usually resolving by bedtime. By 4/15 the numbness was down to a brief period of time and a very small area on her face. Since 4/16 she has not had any further facial numbness.
This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 57-year-old female patient who received SHINGRIX (batch number K2ZY4, expiry date unknown) for prophylaxis. On 26th December 2018, the patient received SHINGRIX (subcutaneous). On 26th December 2018, unknown after receiving SHINGRIX, the patient experienced intramuscular formulation administered by other route. On an unknown date, the patient experienced localized erythema and pain in arm. On an unknown date, the outcome of the intramuscular formulation administered by other route, localized erythema and pain in arm were unknown. It was unknown if the reporter considered the localized erythema and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The pharmacist reported that the patient informed her that the fill-in pharmacist who administered the dose of SHINGRIX to the patient used a subcutaneous syringe to give the vaccine in arm, which led to wrong route of vaccine administration. The pharmacist noted that it could have occurred because they have a box of subcutaneous syringes labeled Shingles, intended for use with ZOSTAVAX. Less than a year, after receiving SHINGRIX, the patient experienced big red place on arm and hurt when she moved her arm. The pharmacist intended to attempt to follow up with the fill-in pharmacist for further discussion.